NEFL and Parkinson disease: We found that baseline NfL levels could replace or complement a number of simple clinical markers previously identified to predict PD progression in a well validated model,21 and while we did not find that NfL alone provided significant additional value to the clinical variables previously identified, the predictive model was strongest when NfL was combined with clinical variables and patient’s genetic status.